UnitedHealth Audit Backs Medical Policy Process but Leaves Denial Application Unreviewed

UnitedHealth Group released an audit of its medical policy development on November 12, 2026, finding the process rigorous but leaving out how those policies are applied in coverage decisions. The review, published by Yahoo, did not evaluate denial rates for the more than 48 million people in the company's insurance plans.

Inside the UnitedHealthcare Policy Review

The audit examined how UnitedHealthcare, the company's insurance unit, creates clinical criteria used to make coverage decisions. FTI Consulting and Rubrum Advising, a medical coverage advisory firm founded by the former chief medical officer of the CMS, conducted the review. The reviewers found the medical policy team of more than 80 people well-staffed and highly qualified, relying on clinical evidence from authoritative groups. They also evaluated a sample of nine medical policies, from molecular testing for blood cancers to a surgery for children with scoliosis, and found them evidence-based and fairly defined. The review identified areas for improvement: UnitedHealthcare lacks explicit documentation for when a new policy should be created or how to vet subject matter experts, and its policies are complex and long, making them difficult for doctors and members to use. "This review was designed to answer a specific question if UnitedHealthcare develops, maintains and oversees its medical policies with rigor and in line with external standards and clinical evidence," a UnitedHealth spokesperson said. CEO Stephen Hemsley said the company welcomes the findings and "will use them to continue strengthening our processes to better serve the people who count on us." The review did not evaluate the specific content of the medical policies or how they are applied in coverage decisions, including any potential cost considerations.

UnitedHealth's Scale and Prior Moves

UnitedHealth Group operates UnitedHealthcare and Optum, serving approximately 100 million people and generating $447.6 billion in FY2025 revenue, according to akta.pro company records. The company reported first quarter 2026 revenue of $111.7 billion, up 2% year-over-year. In May 2026, Optum Rx introduced a fee-based pharmacy care model replacing drug-price-based PBM pricing, with group purchasing converting to flat service fees by 2027. UnitedHealth committed $3 billion to AI investment over 2026-2027, spanning United AI Studio, 117 large language models and more than 1,000 AI use cases.

Earlier Scrutiny and Leadership Changes

UnitedHealth appointed Madeline Bell, former CEO of Children's Hospital of Philadelphia, to its board of directors effective immediately, Stock Titan reported on November 9, 2026. On November 5, 2026, Senator Elizabeth Warren criticized the company's completed $3.3 billion Amedisys deal, citing a recent DOJ settlement as evidence of concern over market power, Simply Wall St reported. The company's board authorized a quarterly cash dividend of $2.32 per share, payable December 15, 2026, to shareholders of record as of December 7, 2026, Stock Titan reported on November 4, 2026.

What Hemsley Said Comes Next

Hemsley said the company would continue the audits and make changes "where needed." A UnitedHealth spokesperson said it was too early to comment on areas of future review but that updates would be shared as available.